News
Live Science on MSN14d
Prader-Willi syndrome: A rare disease that causes insatiable hungerPrader-Willi syndrome is a rare genetic disease that causes poor feeding in infancy but later triggers insatiable hunger.
Pharmaceutical Technology on MSN3d
EMA validates Soleno’s application for Prader-Willi syndrome treatmentThe relentless hunger and associated behaviours significantly impact the quality of life for those with Prader-Willi syndrome ...
DC News Now on MSN13d
National Prader-Willi Syndrome Day: Virginia father turns family’s journey into advocacyMay 15 marks National Prader-Willi Syndrome Awareness Day. For one Virginia father, the date is more than just a spot on the ...
News-Medical.Net on MSN8d
Genetic variations in Prader-Willi syndrome offer key insights into autism and psychosisIn a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized ...
VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to ...
In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized ...
Die Validierung markiert einen bedeutenden Schritt in Solenos Bemühungen, die Behandlung für die PWS-Gemeinschaft in der Europäischen Union verfügbar zu machen. CEO Anish Bhatnagar, M.D., betonte das ...
PWS betrifft nach Schätzungen der Prader-Willi-Syndrom-Vereinigung USA eine von 15.000 Lebendgeburten. Das Hauptsymptom der Störung, Hyperphagie, ist durch unstillbaren Hunger gekennzeichnet und kann ...
VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to U.S. patients. VYKAT XR is indicated for the treatment of hyperphagia in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback